Find My Journal

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Jaafar Bennouna, Javier Sastre, Dirk Arnold, Pia Österlund, Richard Greil, Eric Van Cutsem, Roger von Moos, José María Viéitez, Olivier Bouché, Christophe Borg, Claus-Christoph Steffens, Vicente Alonso-Orduña, C. Schlichting, Irmarie Reyes‐Rivera, Belguendouz Bendahmane, Thierry André, Stefan Kubicka

The Lancet Oncology, 2012

Institut de Cancérologie de l'Ouest, Hospital Clínico San Carlos, University Cancer Center Hamburg, Helsinki University Hospital, Paracelsus Medical University, Universitair Ziekenhuis Leuven, Kantonsspital Graubünden, Hospital Universitario Central de Asturias, Université de Reims Champagne-Ardenne, Centre Hospitalier Universitaire de Reims, Centre Hospitalier Universitaire de Besançon, Elbe Kliniken Stade-Buxtehude, Center for HIV and Hepatogastroenterology, Hospital Universitario Miguel Servet, Agaplesion Diakonieklinikum Rotenburg, Roche (Switzerland), Sorbonne Université, Hôpital Saint-Antoine, Reutlingen University

View Free PDF Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

1160

Citations

View on Google Scholar